CoChat

Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges

Poon, Anna, Zhang, Yu, Chandrasekaran, Abinaya, Phanthong, Phetcharat, Schmid, Benjamin, Nielsen, Troels T., Freude, Kristine K. · 2017 · New Biotechnology
Cited by 46

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbt.2017.05.009

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 71

  1. Duan, 2014, Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death, Mol Neurodegener, 9, 3, 10.1186/1750-1326-9-3 · DOI · Paper page
  2. Sproul, 2014, Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors, PLoS One, 9, e84547, 10.1371/journal.pone.0084547 · DOI · Paper page
  3. Apostolova, 2016, Alzheimer disease, Continuum (Minneap Minn), 22, 419, 10.1212/CON.0000000000000307 · DOI · Paper page
  4. Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun, 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  5. Kosik, 1986, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc Natl Acad Sci U S A, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
  6. Alzheimer, 1911, Über eigenartige Krankheitsfalle des späteren Alters, Zbl ges Neurol Psych, 4, 356, 10.1007/BF02866241 · DOI · Paper page
  7. Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 · DOI · Paper page
  8. Schellenberg, 1993, Chromosome 14 and late-onset familial Alzheimer disease (FAD), Am J Hum Genet, 53, 619
  9. St George-Hyslop, 1987, The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Science, 235, 885, 10.1126/science.2880399 · DOI · Paper page
  10. Jiang, 2013, Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors, Curr Alzheimer Res, 10, 852, 10.2174/15672050113109990155 · DOI · Paper page
  11. Yegambaram, 2015, Role of environmental contaminants in the etiology of Alzheimer's disease: a review, Curr Alzheimer Res, 12, 116, 10.2174/1567205012666150204121719 · DOI · Paper page
  12. Cataldo, 2001, Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders, Ann Neurol, 50, 661, 10.1002/ana.1254 · DOI · Paper page
  13. Mufson, 2002, Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease, J Comp Neurol, 443, 136, 10.1002/cne.10122 · DOI · Paper page
  14. Heneka, 2015, Neuroinflammation in Alzheimer's disease, Lancet Neurol, 14, 388, 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
  15. Balez, 2016, Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease, Sci Rep, 6, 31450, 10.1038/srep31450 · DOI · Paper page
  16. Lancaster, 2014, Generation of cerebral organoids from human pluripotent stem cells, Nat Protoc, 9, 2329, 10.1038/nprot.2014.158 · DOI · Paper page
  17. Asim, 2015, Down syndrome: an insight of the disease, J Biomed Sci, 22, 41, 10.1186/s12929-015-0138-y · DOI · Paper page
  18. Wiseman, 2009, Down syndrome–recent progress and future prospects, Hum Mol Genet, 18, R75, 10.1093/hmg/ddp010 · DOI · Paper page
  19. Weick, 2016, Gene expression studies on human trisomy 21 iPSCs and neurons: towards mechanisms underlying down's syndrome and early Azheimer's disease-like pathologies, Methods Mol Biol, 1303, 247, 10.1007/978-1-4939-2627-5_15 · DOI
  20. Rumble, 1989, Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease, N Engl J Med, 320, 1446, 10.1056/NEJM198906013202203 · DOI · Paper page
  21. Shi, 2008, Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome, J Biol Chem, 283, 28660, 10.1074/jbc.M802645200 · DOI · Paper page
  22. Chang, 2015, N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons, Sci Rep, 5, 8744, 10.1038/srep08744 · DOI
  23. Briggs, 2013, Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology, Stem Cells, 31, 467, 10.1002/stem.1297 · DOI · Paper page
  24. Weick, 2013, Deficits in human trisomy 21 iPSCs and neurons, Proc Natl Acad Sci U S A, 110, 9962, 10.1073/pnas.1216575110 · DOI · Paper page
  25. Bang, 2015, Frontotemporal dementia, Lancet, 386, 1672, 10.1016/S0140-6736(15)00461-4 · DOI · Paper page
  26. DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 · DOI · Paper page
  27. Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 · DOI · Paper page
  28. Rademakers, 2004, The role of tau (MAPT) in frontotemporal dementia and related tauopathies, Hum Mutat, 24, 277, 10.1002/humu.20086 · DOI · Paper page
  29. Capell, 2014, Progranulin transcripts with short and long 5' untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression, J Biol Chem, 289, 25879, 10.1074/jbc.M114.560128 · DOI
  30. Hu, 2009, TDP-43 and frontotemporal dementia, Curr Neurol Neurosci Rep, 9, 353, 10.1007/s11910-009-0052-3 · DOI
  31. Bersano, 2009, Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation, Neurobiol Aging, 30, 752, 10.1016/j.neurobiolaging.2007.08.009 · DOI
  32. Urwin, 2009, The role of CHMP2B in frontotemporal dementia, Biochem Soc Trans, 37, 208, 10.1042/BST0370208 · DOI
  33. Donnelly, 2013, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention, Neuron, 80, 415, 10.1016/j.neuron.2013.10.015 · DOI · Paper page
  34. Biswas, 2016, MMP-9 and MMP-2 contribute to neuronal cell death in iPSC models of frontotemporal dementia with MAPT mutations, Stem Cell Rep, 7, 316, 10.1016/j.stemcr.2016.08.006 · DOI · Paper page
  35. Lee, 2014, Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency, Hum Mol Genet, 23, 1467, 10.1093/hmg/ddt534 · DOI · Paper page
  36. Raitano, 2015, Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia, Stem Cell Rep, 4, 16, 10.1016/j.stemcr.2014.12.001 · DOI
  37. Almeida, 2012, Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects, Cell Rep, 2, 789, 10.1016/j.celrep.2012.09.007 · DOI · Paper page
  38. Zhang, 2017, Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B, Stem Cell Rep, 8, 648, 10.1016/j.stemcr.2017.01.012 · DOI
  39. Shi, 2012, Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks, Nat Protoc, 7, 1836, 10.1038/nprot.2012.116 · DOI · Paper page
  40. Krishnamurthy, 2004, Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model, J Biol Chem, 279, 7893, 10.1074/jbc.M311203200 · DOI · Paper page
  41. Rasmussen, 2016, Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT), Stem Cell Res, 16, 70, 10.1016/j.scr.2015.12.008 · DOI
  42. Rasmussen, 2016, Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT), Stem Cell Res, 16, 75, 10.1016/j.scr.2015.12.006 · DOI
  43. Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 556, 10.1016/j.scr.2016.09.021 · doi:10.1016/j.scr.2016.09.021
  44. Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 576, 10.1016/j.scr.2016.09.020 · doi:10.1016/j.scr.2016.09.020
  45. Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 600, 10.1016/j.scr.2016.09.024 · DOI
  46. Koch, 2011, Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease, Nature, 480, 543, 10.1038/nature10671 · DOI · Paper page
  47. Hansen, 2016, Induced pluripotent stem cell – derived neurons for the study of spinocerebellar ataxia type 3, Stem Cell Res, 17, 306, 10.1016/j.scr.2016.07.004 · DOI
  48. Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196, Stem Cell Res, 16, 199, 10.1016/j.scr.2015.12.049 · doi:10.1016/j.scr.2015.12.049
  49. Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H266, Stem Cell Res, 16, 166, 10.1016/j.scr.2015.12.029 · doi:10.1016/j.scr.2015.12.029
  50. Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271, Stem Cell Res, 16, 159, 10.1016/j.scr.2015.12.027 · doi:10.1016/j.scr.2015.12.027
  51. Mertens, 2016, Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience, Nat Rev Neurosci, 17, 424, 10.1038/nrn.2016.46 · DOI · Paper page
  52. Taroni, 2004, Pathways to motor incoordination: the inherited ataxias, Nat Rev Neurosci, 5, 641, 10.1038/nrn1474 · DOI · Paper page
  53. Su, 2006, Generation of cerebellar neuron precursors from embryonic stem cells, Dev Biol, 290, 287, 10.1016/j.ydbio.2005.11.010 · DOI
  54. Muguruma, 2010, Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells, Nat Neurosci, 13, 1171, 10.1038/nn.2638 · DOI · Paper page
  55. Morino, 2015, A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia, Mol Brain, 8, 89, 10.1186/s13041-015-0180-4 · DOI
  56. Wang, 2015, Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons, Sci Rep, 5, 9232, 10.1038/srep09232 · DOI
  57. Chaudhari, 2016, Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review, Int J Mol Sci, 17, 10.3390/ijms17121974 · DOI · Paper page
  58. Hu, 2016, Micropatterned hydrogel surface with high-aspect-ratio features for cell guidance and tissue growth, ACS Appl Mater Interfaces, 8, 21939, 10.1021/acsami.5b12268 · DOI
  59. Raghavan, 2015, Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays, Gynecol Oncol, 138, 181, 10.1016/j.ygyno.2015.04.014 · DOI
  60. Ivanov, 2014, Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres, PLoS One, 9, e103817, 10.1371/journal.pone.0103817 · DOI · Paper page
  61. Jang, 2015, On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro, Biomicrofluidics, 9, 034113, 10.1063/1.4922863 · DOI
  62. Cui, 2017, Advances in multicellular spheroids formation, J R Soc Interface, 14, 10.1098/rsif.2016.0877 · DOI · Paper page
  63. Schizas, 2014, Hyaluronic acid-based hydrogel enhances neuronal survival in spinal cord slice cultures from postnatal mice, J Biomater Appl, 28, 825, 10.1177/0885328213483636 · DOI
  64. Park, 2010, Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor, J Biomed Mater Res A, 93, 1091, 10.1002/jbm.a.32519 · DOI · Paper page
  65. Kunze, 2011, Micropatterning neural cell sultures in 3D with a multilayered scaffold, Biomaterials, 32, 2088, 10.1016/j.biomaterials.2010.11.047 · DOI
  66. Marton, 2016, Neural differentiation in the third dimension: generating a human midbrain, Cell Stem Cell, 19, 145, 10.1016/j.stem.2016.07.017 · DOI
  67. Preynat-Seauve, 2009, Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture, Stem Cells, 27, 509, 10.1002/stem.20080600 · doi:10.1002/stem.20080600
  68. Tieng, 2014, Engineering of midbrain organoids containing long-lived dopaminergic neurons, Stem Cells Dev, 23, 1535, 10.1089/scd.2013.0442 · DOI
  69. Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517 · DOI · Paper page
  70. Kelava, 2016, Dishing out mini-brains: current progress and future prospects in brain organoid research, Dev Biol, 420, 199, 10.1016/j.ydbio.2016.06.037 · DOI · Paper page
  71. Zhang, 2016, Layered hydrogels accelerate iPSC-derived neuronal maturation and reveal migration defects caused by MeCP2 dysfunction, Proc Natl Acad Sci U S A, 113, 3185, 10.1073/pnas.1521255113 · DOI · Paper page

Cited by

See all 46

Metadata

Authors
Poon, A., Zhang, Y., Chandrasekaran, A., Phanthong, P., Schmid, B., Nielsen, T. T., & Freude, K. K.
Venue
New Biotechnology
Publisher
Elsevier BV
Published
2017-10
Volume
39
Pages
190-198
ISSN
1871-6784
Cited by
46
References
29
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • The China Scholarship Council
  • Mahidol University research fund
  • The European Union 7th Framework Program
  • Innovation Fund Denmark

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges. https://app.cochat.ai/papers/10.1016/j.nbt.2017.05.009
The paper
Poon, A., Zhang, Y., Chandrasekaran, A., Phanthong, P., Schmid, B., Nielsen, T. T., & Freude, K. K. (2017). Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges. New Biotechnology. https://doi.org/10.1016/j.nbt.2017.05.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.